Latest News
- 
 Kids sometimes get Huntington’s disease tooFinally, a big study that shows what childhood HD looks like. This will help us work out if new drugs work in children too 
- 
 Roche announces details of its 'pivotal' huntingtin-lowering studyThe GENERATION-HD1 trial will test whether RG6042 – formerly Ionis-HTTRx – slows the progression of Huntington's disease 
- 
 Disappointing news from LEGATO-HD trial of laquinimod in Huntington's diseaseThe LEGATO-HD trial of laquinimod did not slow progression of Huntington's disease. Here's the lowdown. 
- 
 HDBuzz Enrolls in Enroll-HDAs promised, HDBuzz's Jeff Carroll finally signed up for the Enroll-HD study. Learn more about this important global HD "observational study" here. 
- 
 First Dolly, now Piglet; a new Huntington’s disease pig knock-in model confirmedFor the first time in HD research, an animal model has been created in pigs using 2 cutting edge DNA editing t 
- 
 New collaboration seeks to speed Huntington's disease drug licensingCritical Path Institute launches new initiative to get HD drugs licensed as quickly as possible 
- 
 HDSA’s Q&A on the latest huntingtin-lowering update from Ionis and RocheOur friends at @hdsa have produced this really good Q&A document about the latest huntingtin-lowering news. 
- 
 Exciting Experiments in "Open Science" by Huntington's ResearchersBrave scientists open their notebooks to help drive HD research at the risk of getting "scooped". 
- 
 The structure of the protein that causes Huntington's disease, revealedHuntingtin protein's structure is now clear thanks to cryo-electron microscopy. This is kind of a big deal 
- 
 Huntington's disease therapeutics conference 2018 – day 3Updates from day 3 of the Huntington’s Disease Therapeutics Conference: huntingtin protein – and lowering it 
